Upload Avatar (500 x 500)
Jia Wei
Medical School
Nanjing University
Jiangsu
Language: English, Chinese
Gastric Cancer
Personalized Medicine
Molecular Typing
Neoantigen
Cell Therapy
Immunotherapy
Clinical Research
Oncology
Cancer Treatment
Medical Research
Areas of Focus
- Personalized Treatment of Gastric Cancer
- Tumor Immunotherapy
Work Experience
- Current - Nanjing University Medical School Affiliated Drum Tower Hospital - Chief Physician/Professor
- Current - Nanjing University Clinical Cancer Research Institute - Deputy Director
- Current - eLife Journal - Editor
- Current - BMC Cancer, Translational Cancer Research, Frontiers in Oncology - Editorial Board Member
Academic Background & Achievements
- Ph.D. in Medical Oncology: Nanjing University
- Fellow: Harvard Medical School/Massachusetts General Hospital/Dana-Farber Cancer Institute
- Youth Scholar: Ministry of Education's Changjiang Scholars Program
- Chief Scientist: Major Special Project of Science and Technology, Ministry of Science and Technology
Publications
- Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors, Chen F, Zou Z, Du J, Su S, Shao J, Meng F, Yang J, Xu Q, Ding N, Yang Y, Liu Q, Wang Q, Sun Z, Zhou S, Du S, Wei J, Liu B, 2019
- iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer, Ding N, Zou Z, Sha H, Su S, Qian H, Meng F, Chen F, Du S, Zhou S, Chen H, Zhang L, Yang J, Wei J, Liu B, 2019
- DKK1 promotes tumor immune evasion and impedes anti-PD-1 treatment by inducing immunosuppressive macrophages in gastric cancer, Shi T, Zhang Y, Wang Y, Song X, Wang H, Zhou X, Liang K, Luo Y, Che K, Wang X, Pan Y, Liu F, Yang J, Liu Q, Yu L, Liu B, Wei J, 2022
- Nitric Oxide-Driven Nanomotor for Deep Tissue Penetration and Multidrug Resistance Reversal in Cancer Therapy, Wan MM, Chen H, Da Wang Z, Liu ZY, Yu YQ, Li L, Miao ZY, Wang XW, Wang Q, Mao C, Shen J, Wei J, 2020
- Deep Penetration of Nanolevel Drugs and Micrometer-Level T Cells Promoted by Nanomotors for Cancer Immunochemotherapy, Chen H, Shi T, Wang Y, Liu Z, Liu F, Zhang H, Wang X, Miao Z, Liu B, Wan M, Mao C, Wei J, 2021
- Systematic Research and Evaluation Models of Nanomotors for Cancer Combined Therapy, Wan M, Wang Q, Li X, Xu B, Fang D, Li T, Yu Y, Fang L, Wang Y, Wang M, Wang F, Mao C, Shen J, Wei J, 2020
- Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation, Zhou S, Meng F, Du S, Qian H, Ding N, Sha H, Zhu M, Yu X, Wang L, Liu B, Wei J, 2021
- Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study, Peng Z, Liu T, Wei J, Wang A, He Y, Yang L, Zhang X, Fan N, Luo S, Li Z, Gu K, Lu J, Xu J, Fan Q, Xu R, Zhang L, Li E, Sun Y, Yu G, Bai C, Liu Y, Zeng J, Ying J, Liang X, Xu N, Gao C, Shu Y, Ma D, Dai G, Li S, Deng T, Cui Y, Fang J, Ba Y, Shen L, 2021
- NIR-Activated Multimodal Photothermal/Chemodynamic/Magnetic Resonance Imaging Nanoplatform for Anticancer Therapy by Fe(II) Ions Doped MXenes (Fe-Ti3 C2 ), Wu Y, Song X, Xu W, Sun KY, Wang Z, Lv Z, Wang Y, Wang Y, Zhong W, Wei J, Cai HL, Wu X, 2021
- Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma, Peng Z, Wei J, Wang F, Ying J, Deng Y, Gu K, Cheng Y, Yuan X, Xiao J, Tai Y, Wang L, Zou J, Zhang Y, Shen L, 2021
- Two biomarker-directed randomized trials in European and Chinese patients with non-small-cell lung cancer: The BRCA1-RAP80 Expression Customization (BREC) studies, Moran T, Wei J, Cobo M, et al, 2014
- Tumor neoantigens: from basic research to clinical applications, Jiang T, Shi T, Zhang H, Hu J, Song Y, Wei J, Ren S, Zhou C, 2019
- mRNA Expression of BRCA1, PIAS1, and PIAS4 and Survival After Second-line Docetaxel in Advanced Gastric Cancer, Wei J, Costa C, Ding Y, et al, 2011
Awards
- 2020: Youth Scholar, Ministry of Education's Changjiang Scholars Program
- 2020: China Youth May Fourth Medal
- 2020: Young Scientist in Oncology, China
- 2020: Wu Mengchao Medical Youth Fund Award
- 2020: People's Good Doctor (Gastric Cancer Field) Jinshan Camellia Outstanding Contribution Award
- 2020: Second Prize, Jiangsu Province New Technology Introduction
- 2019: First Prize, Jiangsu Province Science and Technology Award
- 2019: First Prize, Jiangsu Province Medical Science and Technology Award
- 2018: JSMO 2018 Young Investigator Award
- 2017: Second Prize, Ministry of Education Science and Technology Progress Award
- 2015: First Prize, Jiangsu Province New Technology Introduction Award
- 2015: Third Prize, Chinese Medical Award
- 2015: Second Prize, Jiangsu Province Science and Technology Award
- 2015: Second Prize, Jiangsu Province Medical Science and Technology Award
- 2012: Second Prize, Jiangsu Province Science and Technology Award
- 2011: Second Prize, Chinese Medical Science and Technology Award
- 2012: Second Prize, China Anti-Cancer Association Science and Technology Award
- 2011: Second Prize, Jiangsu Province Medical Science and Technology Award
- 2008: Third Prize, China Oncology Conference
- 2007: First Prize, Jiangsu Province New Technology Introduction Award
